PT METRO HEALTHCARE INDONESIA TBK Financials PT Metro Healthcare Indonesia Tbk
Equities
CARE
ID1000154909
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 175 IDR | +1.16% |
|
+6.71% | +9.38% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Capitalization 1 | 1,07,06,500 | 1,71,23,750 | 1,58,27,000 | 53,20,000 |
| Enterprise Value (EV) 1 | 1,00,97,183 | 1,67,75,413 | 1,59,30,829 | 55,19,751 |
| P/E ratio | 748 x | 2,808 x | -169 x | -48 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 49.5 x | 58.9 x | 67.6 x | 21.9 x |
| EV / Revenue | 46.7 x | 57.7 x | 68.1 x | 22.7 x |
| EV / EBITDA | -2,698 x | 534 x | -422 x | -379 x |
| EV / FCF | -19.8 x | -61.1 x | -49.3 x | -96.6 x |
| FCF Yield | -5.04% | -1.64% | -2.03% | -1.04% |
| Price to Book | 3.25 x | 5.19 x | 4.94 x | 1.72 x |
| Nbr of stocks (in thousands) | 3,32,50,000 | 3,32,50,000 | 3,32,50,000 | 3,32,50,000 |
| Reference price 2 | 322.0 | 515.0 | 476.0 | 160.0 |
| Announcement Date | 31/05/21 | 15/08/22 | 03/04/23 | 28/03/24 |
1IDR in Million2IDR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 87,209 | 1,54,077 | 2,16,296 | 2,90,934 | 2,33,971 | 2,42,681 |
| EBITDA 1 | 3,619 | 16,785 | -3,743 | 31,395 | -37,714 | -14,554 |
| EBIT 1 | -3,481 | 8,674 | -15,862 | 14,098 | -60,591 | -36,139 |
| Operating Margin | -3.99% | 5.63% | -7.33% | 4.85% | -25.9% | -14.89% |
| Earnings before Tax (EBT) 1 | -26,060 | -21,524 | 13,793 | 6,507 | -93,316 | -1,06,123 |
| Net income 1 | -27,487 | -24,205 | 14,313 | 6,099 | -93,544 | -1,10,920 |
| Net margin | -31.52% | -15.71% | 6.62% | 2.1% | -39.98% | -45.71% |
| EPS 2 | -10,995 | -3.123 | 0.4305 | 0.1834 | -2.813 | -3.336 |
| Free Cash Flow 1 | -27,836 | -8,04,952 | -5,08,687 | -2,74,357 | -3,23,453 | -57,139 |
| FCF margin | -31.92% | -522.43% | -235.18% | -94.3% | -138.24% | -23.54% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 05/03/20 | 13/04/20 | 31/05/21 | 15/08/22 | 03/04/23 | 28/03/24 |
1IDR in Million2IDR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 5,53,773 | - | - | - | 1,03,829 | 1,99,751 |
| Net Cash position 1 | - | 76,605 | 6,09,317 | 3,48,337 | - | - |
| Leverage (Debt/EBITDA) | 153 x | - | - | - | -2.753 x | -13.73 x |
| Free Cash Flow 1 | -27,836 | -8,04,952 | -5,08,687 | -2,74,357 | -3,23,453 | -57,139 |
| ROE (net income / shareholders' equity) | 353% | -2.16% | 0.51% | 0.19% | -2.88% | -3.51% |
| ROA (Net income/ Total Assets) | -0.49% | 0.36% | -0.34% | 0.23% | -0.9% | -0.54% |
| Assets 1 | 55,59,717 | -66,99,533 | -42,55,975 | 26,50,671 | 1,04,32,017 | 2,05,55,928 |
| Book Value Per Share 2 | -11,294 | 97.70 | 98.90 | 99.20 | 96.40 | 93.10 |
| Cash Flow per Share 2 | 3,174 | 0.3000 | 15.80 | 16.30 | 16.00 | 15.80 |
| Capex 1 | 8,224 | 3,63,310 | 5,22,268 | 3,10,405 | 2,90,454 | 12,562 |
| Capex / Sales | 9.43% | 235.8% | 241.46% | 106.69% | 124.14% | 5.18% |
| Announcement Date | 05/03/20 | 13/04/20 | 31/05/21 | 15/08/22 | 03/04/23 | 28/03/24 |
1IDR in Million2IDR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +9.38% | 358M | |
| -19.34% | 16.51B | |
| +5.41% | 12.53B | |
| +4.64% | 11.74B | |
| +2.21% | 10.06B | |
| +29.11% | 8.71B | |
| -3.46% | 7.57B | |
| +18.60% | 7.14B | |
| +5.17% | 6.68B | |
| +44.78% | 4.54B |
- Stock Market
- Equities
- CARE Stock
- Financials PT Metro Healthcare Indonesia Tbk
